Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › ATG

ATG

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of ATG

5 trials tracked of ATG.

5Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 3 Phase 1 1 Other / NA 1
  1. Phase 2 Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation Completed
  2. Phase 2 UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep Completed
  3. Phase 2 A Dose Escalation Study in de Novo Renal Transplantation Completed
  4. Phase 1 Renal Allograft Tolerance Through Mixed Chimerism (Belatacept) Completed
  5. N/A Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Low-dose ATG plus PTCy shows no significant difference in acute GVHD compared to standard regimens
Hematology RCT
Low-dose ATG plus PTCy shows no significant difference in acute GVHD compared to standard regimens Trial Shows New Treatment Strategy for Leukemia Stem Cell Transplant
This randomized trial of 407 patients with AML or MDS undergoing haploidentical transplant found that low-dose ATG plus PTCy did not signifi…
A new combination of medications may help patients recover blood cells faster after a stem cell transplant for leukemia or blood disorders.
Blood Jun 25, 2026